Common side effects of Wegovy: what to expect and when to act

Which side effects do most people on Wegovy actually get?

Nausea is the one people mention most. In the STEP 1 trial, the majority of participants on semaglutide 2.4mg reported some digestive discomfort, particularly early on. Diarrhoea and constipation can both occur, sometimes alternating; vomiting, reflux, burping and stomach bloating are also common. Fatigue and headache show up in a meaningful minority of users, as do dizziness and injection-site redness or itching.

Loose stools deserve a note of their own: for some people they're watery rather than simply frequent, which matters for hydration. The pattern of liquid diarrhoea with Wegovy is well documented, and staying on top of fluid intake is straightforward but important. If vomiting and diarrhoea are both happening at once, dehydration can follow quickly.

The good news, if you want it plainly stated, is that most of these effects are predictable. The dose escalation schedule exists precisely because starting low and moving gradually gives your system time to adapt. A question our prescribers hear regularly is whether the side effects mean treatment isn't working, they don't. They usually mean it is.

For a broader picture of how semaglutide behaves across different situations, you can read about the common side effects of semaglutide before exploring the full Wegovy side effects guide, which covers the complete profile in more depth.

Why do Wegovy side effects tend to peak at the start?

Semaglutide slows gastric emptying, food moves through the stomach more gradually. That mechanism is central to how it reduces appetite, but it is also why the gut reacts when the dose goes up. Your digestive system is being asked to operate differently, and the initial response is often protest.

The nausea typically tracks the dose: it tends to reappear or worsen each time the prescription moves to the next level, then settles again. Eating smaller portions, avoiding very fatty or spicy food and not lying down immediately after eating can all help without requiring any change to treatment. These aren't tricks; they're the practical guidance behind the NHS's own advice for people taking semaglutide.

Most people find the side effects at the 2.4mg maintenance dose are actually more tolerable than they were at earlier steps, because the body has had months to adjust by that point. That said, everyone is different, and some people find one particular dose step harder than others. Slowing down the escalation schedule is something a prescriber can discuss if symptoms are genuinely disruptive.

If you're curious about how often nausea specifically affects people starting treatment, this page looks at the frequency data in more detail.

When do common side effects cross a line that needs medical attention?

This is the section worth reading carefully. Most GI side effects are unpleasant rather than dangerous. A handful of signs are different.

Severe stomach pain that persists and may radiate through to the back (with or without vomiting) can indicate acute pancreatitis. This is an infrequent but serious reaction to GLP-1 medicines. In January 2026 the MHRA issued a Drug Safety Update specifically highlighting pancreatitis risk across this class of medicine; the guidance is clear that anyone with those symptoms should seek urgent medical help rather than waiting to see if it passes.

Signs of a gallbladder problem (sudden pain in the upper right abdomen, particularly after eating) also warrant prompt assessment. Severe allergic reactions are rare but recognisable: swelling of the face, throat or tongue, difficulty breathing, or a rapid pulse. Don't wait on any of these.

Dehydration from prolonged vomiting or diarrhoea is worth taking seriously too, particularly if you're passing very little urine or feel confused or faint. Get medical help the same day rather than pushing through.

If you're unsure whether what you're experiencing is a common adjustment effect or something that needs attention, the clinical team at nume provides aftercare seven days a week, and your prescriber's guidance always takes precedence over anything you read online, including this page.

Any suspected side effect can be reported through the MHRA Yellow Card scheme, which is open to patients as well as healthcare professionals.

Does the newer 7.2mg Wegovy dose change the side effect picture?

The MHRA approved the 7.2mg single-dose Wegovy pen in April 2026 for adults with a BMI of 30 or above. It reaches a higher maintenance dose than the standard 2.4mg regimen, and the titration approach remains gradual: the starting dose is still 0.25mg, moved up by the prescriber at each monthly review.

A higher maintenance dose can mean more pronounced GI effects for some people, particularly during the steps that bridge up to 7.2mg. The principle remains the same (slow escalation, small meals, adequate hydration) but the potential for side effects at the top of the schedule is worth factoring into the conversation with a prescriber before starting.

For context on whether Wegovy suits your circumstances, the Wegovy overview covers the full licensed picture, and cost context sits on the Wegovy pricing page for anyone weighing up the options. Treatment suitability, including how side effects might affect someone's particular situation, is worked through during a consultation, the free consultation with our prescribers is the practical next step.